BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R.1105, Omnibus Appropriations Act, 2009, Issues related to safe injection practices H.R.1 (PL 111-5), American Recovery and Reinvestment Act of 2009, Issues related to funding for HAI prevention
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANTHONY LAKAVAGE | — |
| PAUL SELTMAN | — |
Health Issues HCR
H.R. 759, Food and Drug Administration Globalization Act of 2009, Issues related to import safety S.301, Physician Payments Sunshine Act of 2009, Issues related to medical device company/physician relationship Issues related to FDA regulation of diagnostic tests H.R. 1346, Medical Device Safety Act of 2009, Issues relating to pre-emption S. 540, Medical Device Safety Act of 2009, Issues relating to pre-emption Issues related to federal pedigree legislation Healthcare-associated infections, presentation of company's policy position
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANTHONY LAKAVAGE | — |
| PAUL SELTMAN | — |
Medicare/Medicaid MMM
Proposed legislation related to sharps and safe needle disposal
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.